Global Nutraceuticals Market Research Report - Forecast to 2027

The global nutraceuticals market has witnessed a repetitive growth over the last few years, and it is estimated to reach USD 319.6 billion at a CAGR of 6.70% during the forecast period of 2017–2023.

Reference: 180220
Price: $6,250.00
Tax included

General

Publisher:
Market Research Future
Geography Covered
Global
Publication Date
2017/11/30
Pages
97
Language
  • English
Format
License

The global nutraceuticals market has witnessed a repetitive growth over the last few years, and it is estimated to reach USD 319.6 billion at a CAGR of 6.70% during the forecast period of 2017–2023.
Manufacturers invest in research and technology development and investigative activities to improve existing products and procedures in order to develop new products. The research and development will lead to the development of new products to improve the quality of the products and improve their functionality by experimenting with better ingredients to give a balanced diet. The key industrial players have been developing better-for-you products to accommodate the healthy food movement in convenient packaging, with clean labels ensuring food safety for their consumers.
Asia Pacific is considered to be the second largest hub for nutraceuticals after North America. The consumption of nutraceuticals is identified to be the highest in Japan and China. Both Japan and China together constitute about 78.04% of the total market of nutraceuticals in the Asia Pacific region. The escalating consumption of dietary supplement for fine body metabolism is supporting the sale of nutraceuticals in these countries of the region. The presence of multi-national companies involved in the production of nutraceuticals and running awareness campaigns are adding fuel to the market growth of nutraceuticals in this region. The rising per capita disposable income is also observed to be a key driver for this market in Asia Pacific. Better knowledge about functional food is capturing consumers’ attention towards the nutraceuticals product line. Additionally, India is the potential destination for nutraceutical manufacturers with a huge untapped market.
Regional Analysis
The global nutraceuticals market is segmented into North America, Europe, Asia Pacific, and the rest of the world. The North American region is estimated to account for a significant market proportion in the global nutraceuticals market, and the trend is expected to continue throughout the forecast period of 2017–2023. Asia Pacific is also expected to witness a maximum growth rate of 7.82% during the review period of 2017–2023.

Segments
The nutraceuticals market has been segmented on the basis of type which comprises functional beverages, functional foods, and dietary supplements.
On the basis of ingredients, the nutraceuticals market has segmented into vitamins and minerals, probiotics, protein and peptides, omega-3, and others.
The nutraceuticals market has been segmented on the basis of distribution channel into store-based and non-store-based.

Key Players
The leading market players in the global nutraceuticals market primarily Archer-Daniels-Midland Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), BASF SE (Germany), GlaxoSmithKline Plc (U.K), DSM Nutritional Products, Inc. (the Netherlands), Abbott Nutrition Manufacturing Inc. (U.S.), and Cargill Inc. (U.S.)
Target Audience
• Food & beverages manufacturers
• Nutraceuticals manufacturers
• Raw material suppliers
• End-users (food & beverages industry)
• Retailers and wholesalers
• E-commerce companies
• Traders, importers, and exporters

Key Findings
• Among type, the functional foods segment is expected to account for a major market proportion during the forecast period of 2017–2023. However, dietary supplements are projected to expand at a high growth rate of 6.88% during the forecast period.
• Among ingredients, the vitamins and minerals segment is expected to witness a growth rate of 6.61% during the forecast period of 2017–2023. Omega- 3 is projected to expand at a high growth rate of 8.23% during the forecast period.
Regional & Country Analysis of the Nutraceuticals Market, Development & Demand Forecast to 2023
As per the MRFR analysis, the global nutraceuticals market is estimated to reach USD 319.6 billion during the forecast period 2017 to 2023 at a CAGR of 6.70%.

Country-Level Analysis
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o Netherlands
o Italy
o U.K.
o Rest of Europe
• Asia Pacific
o Japan
o India
o China
o Australia
o Rest of Asia Pacific
• Rest of the World
o Latin America
o Middle East
o Africa

1 Introduction
1.1 Definition
1.1.1 Nutraceuticals
1.2 Scope of the Study
1.2.1 Research Methodology
1.3 Assumptions
1.4 Limitations
1.5 Market Structure
1.6 Research Process/Methodology
1.7 Primary Research
1.8 Secondary Research
1.9 Forecast Model
2 Executive Summary
3 Premium Insights
3.1 Global Nutraceuticals Market: Market Mapping & Research Methodology
3.2 Market Overview: Global Nutraceuticals Market
3.3 Industry Trends and Market Environment: Global Nutraceuticals Market
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising cases of obesity among the consumers
4.2.2 Increasing medical service costs
4.2.3 Strong performance of retail sector
4.2.4 Increasing older consumer’s population
4.3 Restraints
4.3.1 Stringent regulations
4.3.2 High production cost
4.4 Opportunities
4.4.1 R&D investments and new product developments
4.4.2 Innovative packaging
4.4.3 Escalation in preventive healthcare
4.5 Challenges
4.5.1 Product Adulteration
4.5.2 Lack of consumers awareness


5 Mega Trends
5.1 Trends in Nutraceuticals Market
5.2 Macroeconomic indicators analysis
6 Market Factor Analysis
6.1 Introduction
6.2 Value Chain Analysis
6.3 Supply Chain Analysis
6.4 Porter's Five Forces
6.4.1 Porter's 5 Forces Analysis: Nutraceuticals Market
6.4.2 Threat of New Entrants
6.4.3 Threat of Substitutes
6.4.4 Bargaining Power of Buyers
6.4.5 Bargaining Power of Suppliers
6.4.6 Intensity of Rivalry
7 Global Nutraceuticals Market, By Type
7.1 Introduction
7.2 Global Nutraceuticals Market Segmentation, By Type
8 Global Nutraceuticals Market, By Ingredient
8.1 Introduction
9 Global Nutraceuticals Market, By Distribution Channel
9.1 Introduction
10 North America Nutraceuticals Market Analysis
10.1 Introduction
10.2 North America Nutraceuticals Market, By Country
10.3 North America Nutraceuticals Market, By Type
10.4 North America Nutraceuticals Market, By Ingredient
10.5 North America Nutraceuticals Market, By Distribution Channel
10.6 U.S.
10.7 Canada
10.8 Mexico
11 Europe Nutraceuticals Market Analysis
11.1 Introduction
11.2 Europe Nutraceuticals Market, By Country
11.3 Europe Nutraceuticals Market, By Type
11.4 Europe Nutraceuticals Market, By Ingredient
11.5 Europe Nutraceuticals Market, By Distribution Channel
11.6 Germany
11.7 France
11.8 Netherlands
11.9 Italy
11.1 U.K.
11.11 Rest of Europe
12 Asia Pacific Nutraceuticals Market Analysis
12.1 Introduction
12.2 Asia Pacific Nutraceuticals Market, By Country
12.3 Asia Pacific Nutraceuticals Market, By Type
12.4 Asia Pacific Nutraceuticals Market, By Ingredient
12.5 Asia Pacific Nutraceuticals Market, By Distribution Channel
12.6 Japan
12.7 India
12.8 China
12.9 Australia
12.1 Rest of Asia Pacific
13 Rest of the World Nutraceuticals Market Analysis
13.1 Introduction
13.2 Rest of the World Nutraceuticals Market, By Region
13.3 Rest of the World Nutraceuticals Market, By Type
13.4 Rest of the World Nutraceuticals Market, By Ingredient
13.5 Rest of the World Nutraceuticals Market, By Distribution Channel
13.6 Latin America
13.7 Middle East
13.8 Africa
14 Competitive Landscape
15 Company Profiles
15.1 Archer-Daniels-Midland Company
15.1.1 Company Overview
15.1.2 Financials
15.1.3 Products
15.1.4 Strategy
15.1.5 Key Developments
15.2 BASF SE
15.2.1 Company Overview
15.2.2 Financials
15.2.3 Products
15.2.4 Strategy
15.2.5 Key Developments
15.3 E. I. du Pont de Nemours and Company
15.3.1 Company Overview
15.3.2 Financials
15.3.3 Products
15.3.4 Strategy
15.3.5 Key Developments
15.4 GlaxoSmithKline Plc
15.4.1 Company Overview
15.4.2 Financials
15.4.3 Products
15.4.4 Strategy
15.4.5 Key Developments
15.5 Company Overview
15.5.1 Company Overview
15.5.2 Financials
15.5.3 Products
15.5.4 Strategy
15.5.5 Key Developments
15.6 Abbott Nutrition Manufacturing Inc.
15.6.1 Company Overview
15.6.2 Financials
15.6.3 Products
15.6.4 Strategy
15.6.5 Key Developments
15.7 DSM Nutritional Products, Inc.
15.7.1 Company Overview
15.7.2 Financials
15.7.3 Products
15.7.4 Strategy
15.7.5 Key Developments
15.8 Cargill Inc.
15.8.1 Company Overview
15.8.2 Financials
15.8.3 Products
15.8.4 Strategy
15.8.5 Key Developments

Scroll